Related references
Note: Only part of the references are listed.Alzheimer's disease: experimental models and reality
Eleanor Drummond et al.
ACTA NEUROPATHOLOGICA (2017)
Tau-Directed Immunotherapy: A Promising Strategy for Treating Alzheimer's Disease and Other Tauopathies
Sulana K. Schroeder et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2016)
18F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer Disease
Ryuichi Harada et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers
Ruben Smith et al.
BRAIN (2016)
Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages
Adam J. Schwarz et al.
BRAIN (2016)
The amyloid cascade hypothesis: are we poised for success or failure?
Eric Karran et al.
JOURNAL OF NEUROCHEMISTRY (2016)
True alignment of preclinical and clinical research to enhance success in CNS drug development: a review of the current evidence
Pascal J. D. Goetghebeur et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Riluzole rescues alterations in rapid glutamate transients in the hippocampus of rTg4510 mice
Holly C. Hunsberger et al.
METABOLIC BRAIN DISEASE (2016)
Imaging the accumulation and suppression of tau pathology using multiparametric MRI
Holly E. Holmes et al.
NEUROBIOLOGY OF AGING (2016)
Tau and Aβ imaging, CSF measures, and cognition in Alzheimer's disease
Matthew R. Brier et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's Disease
Francesco Panza et al.
BIOMED RESEARCH INTERNATIONAL (2016)
Hyperactivity with Agitative-Like Behavior in a Mouse Tauopathy Model
Pia Jul et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
PERK inhibition prevents tau-mediated neurodegeneration in a mouse model of frontotemporal dementia
Helois Radford et al.
ACTA NEUROPATHOLOGICA (2015)
Alzheimer's Disease: Lessons Learned from Amyloidocentric Clinical Trials
Andreas Soejitno et al.
CNS DRUGS (2015)
Increased cerebral vascular reactivity in the tau expressing rTg4510 mouse: evidence against the role of tau pathology to impair vascular health in Alzheimer's disease
Jack A. Wells et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2015)
Sustained Arginase 1 Expression Modulates Pathological Tau Deposits in a Mouse Model of Tauopathy
Jerry B. Hunt et al.
JOURNAL OF NEUROSCIENCE (2015)
Decreased amyloid-β and increased neuronal hyperactivity by immunotherapy in Alzheimer's models
Marc Aurel Busche et al.
NATURE NEUROSCIENCE (2015)
Tau depletion prevents progressive blood-brain barrier damage in a mouse model of tauopathy
Laura J. Blair et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2015)
A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity
Zeshan Ahmed et al.
ACTA NEUROPATHOLOGICA (2014)
Effects of the C57BL/6 strain background on tauopathy progression in the rTg4510 mouse model
Rachel M. Bailey et al.
MOLECULAR NEURODEGENERATION (2014)
Age-related decline in white matter integrity in a mouse model of tauopathy: an in vivo diffusion tensor magnetic resonance imaging study
Naruhiko Sahara et al.
NEUROBIOLOGY OF AGING (2014)
Therapeutics of Alzheimer's disease: Past, present and future
R. Anand et al.
NEUROPHARMACOLOGY (2014)
Histone deacetylase 6 inhibition improves memory and reduces total tau levels in a mouse model of tau deposition
Maj-Linda Selenica et al.
ALZHEIMERS RESEARCH & THERAPY (2014)
Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models
Scott J. Webster et al.
FRONTIERS IN GENETICS (2014)
Synaptic alterations in the rTg4510 mouse model of tauopathy
Katherine J. Kopeikina et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2013)
Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study
Nicolas Villain et al.
BRAIN (2012)
Targeting Phospho-Ser422 by Active Tau Immunotherapy in the THY-Tau22 Mouse Model: A Suitable Therapeutic Approach
Laetitia Troquier et al.
CURRENT ALZHEIMER RESEARCH (2012)
Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival
Paul Morgan et al.
DRUG DISCOVERY TODAY (2012)
Strain Background Influences Neurotoxicity and Behavioral Abnormalities in Mice Expressing the Tetracycline Transactivator
Harry J. Han et al.
JOURNAL OF NEUROSCIENCE (2012)
Sex difference in pathology and memory decline in rTg4510 mouse model of tauopathy
Mei Yue et al.
NEUROBIOLOGY OF AGING (2011)
Accelerating drug discovery for Alzheimer's disease: best practices for preclinical animal studies
Diana W. Shineman et al.
ALZHEIMERS RESEARCH & THERAPY (2011)
Immunotherapy Targeting Pathological Tau Prevents Cognitive Decline in a New Tangle Mouse Model
Allal Boutajangout et al.
JOURNAL OF NEUROSCIENCE (2010)
Decreased locomotor activity in mice expressing tTA under control of the CaMKIIα promoter
B. C. McKinney et al.
GENES BRAIN AND BEHAVIOR (2008)
Roles of heat-shock protein 90 in maintaining and facilitating the neurodegenerative phenotype in tauopathies
Wenjie Luo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Accumulation of pathological tau species and memory loss in a conditional model of tauopathy
Zdenek Berger et al.
JOURNAL OF NEUROSCIENCE (2007)
Region-specific dissociation of neuronal loss and neurofibrillary pathology in a mouse model of tauopathy
TL Spires et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L)
M Ramsden et al.
JOURNAL OF NEUROSCIENCE (2005)
Tau suppression in a neurodegenerative mouse model improves memory function
K SantaCruz et al.
SCIENCE (2005)
Modified GFAP promoter auto-regulates tet-activator expression for increased transactivation and reduced tTA-associated toxicity
MD Barton et al.
MOLECULAR BRAIN RESEARCH (2002)
Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein
J Lewis et al.
NATURE GENETICS (2000)
Share Paper
